Introduction
Autosomal recessive mutations in the immunoglobulin μ-binding protein 2 gene (IGHMBP2) have been associated with two distinct phenotypes: spinal muscle atrophy with respiratory distress type 1 (SMARD1) and, more recently, Charcot-Marie-Tooth disease type 2S (CMT2S). In SMARD1, degeneration of alpha motor neurons of the spinal cord results in diaphragmatic paralysis and distal muscular atrophy. Sensory and autonomic nerves are also affected in some patients. The disorder usually starts in infancy and early death due to respiratory distress is a hallmark of the disease, although patients with milder phenotypes (later onset and survival until 15-20 years of age) have been described [1, 2] . In contrast, patients with CMT2S develop an axonal neuropathy manifesting with slowly progressive, distal-predominant muscle weakness and sensory loss with preserved respiratory function [3, 4] .
We describe a case of motor and sensory axonal neuropathy associated with respiratory involvement and severe gastrointestinal organ-specific autonomic dysfunction due to a novel missense mutation in IGHMBP2, demonstrating that IGHMBP2 related disorders can result in a severe peripheral neuropathy with enteral autonomic dysfunction.
Case report
The patient was evaluated in the inherited neuropathy clinic in the Centre for This study was approved by the local research ethics committee.
Clinical history and phenotype.
The patient was the eldest daughter of two siblings born to consanguineous healthy parents of Iranian origin. Her family history was unremarkable. She presented with hypotonia and delayed walking during infancy. Despite this, she was able to walk independently until 4 years of age, when she started to use ankle-foot orthoses. By 6 years of age, she was wheelchair-bound. Following an episode of pneumonia at 9 years of age, she was started on nocturnal non-invasive ventilation and over the subsequent Nerve conduction studies performed at age 27 years revealed absent sensory and motor responses throughout. Needle EMG showed severe chronic denervation in proximal muscles of the upper limbs (biceps and deltoid). (supplementary table 1 ) and we therefore decided to proceed with targeted multi-gene panel testing to confirm the absence of mutations in common neuropathy-related genes. Interestingly, the targeted multi-gene panel detected the same variant in IGHMBP2 detected by WES but in homozygosity (see supplementary table 2 for genes included and alignment statistics). In silico analyses revealed that, this variant involved an evolutionarily conserved amino acid, and was predicted to be pathogenic (supplementary material). The homozygous variant was validated by Sanger sequencing and the analysis of parental DNA samples confirmed that both parents were heterozygous carriers.
Genetics studies

Nerve biopsy aged 3
All fascicles in the biopsy were small size ( Figure 2 ). Nerve fibers across the fascicles were small and moderately thinly myelinated. There was no evidence of ongoing active axonal degeneration or demyelination and no inflammatory infiltrates were observed.
Teased fiber preparation showed uniformly short internodes suggesting some regeneration. Electronic microscopy revealed some myelinated fibers with reduplicated basement membranes and a few small clusters of regeneration.
Discussion
We describe a patient with childhood onset autosomal recessive motor and sensory neuropathy with severe organ-specific autonomic dysfunction due to a novel IGHMBP2 missense variant. The mutation was miscalled as a heterozygous allele on whole exome sequencing due to poor coverage but was detected in homozygosity using a targeted gene panel.
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The present case has features that diverge from classical SMARD1 and CMT2S phenotypes. In contrast to SMARD1, in which most patients require assisted ventilation within the first year of life and die within the first decade of life, our patient developed respiratory involvement requiring non-invasive ventilation at age 9 years and is still alive in her 30s. Sensory involvement and autonomic dysfunction, including excessive sweating, tachycardia, constipation and bladder dysfunction, have been described in patients with SMARD1 but also in patients with CMT2S due to IGHMBP2 mutations.
Our patient's phenotype is therefore more typical of a severe CMT2S phenotype within the spectrum of IGHMBP2 related disorders.
It is not clear why our patient has autonomic dysfunction restricted to the gastrointestinal tract. To our knowledge, there have been no studies of the enteric plexus in the NMD mouse or in post mortem tissue of patients with SMARD1 or CMT2S.
Autonomic involvement in patients with IGHMBP2-related disorders has been previously bladder dysfunction in association with an axonal sensorimotor neuropathy without respiratory distress, one of whom required surgery for achalasia at age 18 years [4] . It is possible that the patient has more widespread autonomic dysfunction, however, due to the patient's severe disability we were unable to undertake more extensive autonomic function testing
IGHMBP2 encodes a protein belonging to the putative helicase superfamily. It is expressed in developing and adult human brain, with high expression in the cerebellum [3] . It is functionally linked to translation and may be a component of the translational machinery [6, 7] .
We suggest that mutations in IGHMBP2 may cause an early onset severe sensory motor axonal neuropathy in association with severe organ specific autonomic neuropathy affecting the gastrointestinal tract. Occasionally in the patient's biopsy the nerve fibres are aggregating in clusters (A2, arrow), in keeping with minimal regeneration.
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